Jean Zhao

22PUBLICATIONS

198CO-AUTHORS

Molecular targetsPredictive and prognostic markersHaematological tumoursGlycobiologyCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (22)

Sort by Publication Date:

|May 20, 2026

Inhibition of salt-inducible kinases reprograms T cells and antitumor immunity in ovarian cancer.

|May 04, 2026

Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer.

|Feb 27, 2026

Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer.

Xin Cheng, Changli Qian, Erica Holdridge

|Feb 25, 2026

A disease model resource reveals core principles of tissue-specific cancer evolution.

Sebastian Mueller, Niklas de Andrade Krätzig, Markus Tschurtschenthaler

|Feb 18, 2026

Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance.

Yubao Wang, Cherubin Manokaran, Yutian Zou

|Nov 14, 2025

PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesis.

Shuang Tang, Qian Zhou, Johann S Bergholz

Pageof 4

Frequent Collaborators

Johann S Bergholz

Sheheryar Kabraji

Hao Gu

Thomas M Roberts

Qiwei Wang

Gordon J Freeman

Nikolas Kesten

Jing Ni

Panagiotis A Konstantinopoulos

2 joint publications

Henry W Long

Frequent Collaborators

Johann S Bergholz

Sheheryar Kabraji

Hao Gu

Thomas M Roberts